These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4294232)

  • 21. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role and specificity of bordetella lipopolysaccharide in immune reactions.
    Pusztai Z; Csizér Z; Joó I
    Z Immunitatsforsch Allerg Klin Immunol; 1971; 141(2):129-40. PubMed ID: 4323220
    [No Abstract]   [Full Text] [Related]  

  • 23. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in Bordetella pertussis.
    Cameron J
    J Pathol Bacteriol; 1967 Oct; 94(2):367-74. PubMed ID: 4294462
    [No Abstract]   [Full Text] [Related]  

  • 25. Time relationships between injection of antigen and adjuvant. II. Immunosuppression induced by Bordetella pertussis vaccine when given before secondary antigenic stimulation.
    Finger H; Bartoschek M; Emmerling P
    Pathol Microbiol (Basel); 1972; 38(2):93-102. PubMed ID: 4337644
    [No Abstract]   [Full Text] [Related]  

  • 26. [Antigens of Bordetella pertussis and their repercussion in immunization programs against whooping cough].
    Casal Lombos J
    Rev Sanid Hig Publica (Madr); 1971 May; 45(5):575-87. PubMed ID: 4330706
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound].
    Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cell components of Bordetella pertussis and their biological activities].
    Sato Y; Arai H
    Tanpakushitsu Kakusan Koso; 1972; 17(2):139-49. PubMed ID: 4337077
    [No Abstract]   [Full Text] [Related]  

  • 29. [Influence of Bordetella pertussis on the lymphatic tissue of mice. VI. Further studies regarding the influence of Bordetella pertussis on the immunological memory response].
    Finger H; Emmerling P; Fölmer I; Bartoschek M
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(4):295-308. PubMed ID: 4335600
    [No Abstract]   [Full Text] [Related]  

  • 30. Antigenic structure and phase variation in Bordetella pertussis.
    Nakase Y; Takatsu K; Kasuga T
    Jpn J Microbiol; 1969 Sep; 13(3):283-91. PubMed ID: 4310290
    [No Abstract]   [Full Text] [Related]  

  • 31. Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests.
    Preston NW; Garrity P
    J Pathol Bacteriol; 1967 Apr; 93(2):483-92. PubMed ID: 4293307
    [No Abstract]   [Full Text] [Related]  

  • 32. [Developmental trends in pertussis vaccines].
    Milleck J; Ocklitz HW
    Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1285-7. PubMed ID: 4335598
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypersensitivity in mice. II. The effect of chemical compounds on systemic active anaphylaxis and on anaphylaxis-like reactions in normal and B. pertussis-pretreated mice.
    Dietrich FM; Komarek A; Pericin C
    Int Arch Allergy Appl Immunol; 1971; 40(4-5):495-506. PubMed ID: 4102842
    [No Abstract]   [Full Text] [Related]  

  • 34. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The reactivity of mice after hyperimmunization with Bordetella pertussis.
    David C; Pozsgi N; Andreescu V; Caffé I
    Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):313-8. PubMed ID: 4377531
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities].
    Atakan Ablay P; Ozcengiz E
    Mikrobiyol Bul; 2007 Jan; 41(1):11-20. PubMed ID: 17427548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunologic study of surface antigen extracted with sodium deoxycholate from the whooping cough microbe].
    Demina AA; Larina LI; Gracheva AM; Stanislavskiĭ ES
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Feb; 44(2):36-9. PubMed ID: 4302272
    [No Abstract]   [Full Text] [Related]  

  • 38. [ANTIGENIC, TOXIC AND PROTECTIVE PROPERTIES OF THE CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS].
    DEMINA AA; STANISLAVSKII ES; LARINA LI
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Apr; 41():17-22. PubMed ID: 14221633
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of culture methods on the biological activities of Bordetella pertussis].
    Hirayanagi F
    Nihon Saikingaku Zasshi; 1969 Jan; 24(1):8-14. PubMed ID: 4306072
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
    Canthaboo C; Xing D; Corbel M
    Dev Biol Stand; 1999; 101():95-103. PubMed ID: 10566781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.